COMMUNIQUÉ DE PRESSE

par CompuGroup Medical SE & Co. KGaA (isin : DE000A288904)

E-prescriptions new standard in Germany: CGM with positive interim assessment

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Miscellaneous
E-prescriptions new standard in Germany: CGM with positive interim assessment

30.01.2024 / 09:40 CET/CEST
The issuer is solely responsible for the content of this announcement.


E-prescriptions new standard in Germany: CGM with positive interim assessment

 

Koblenz. In the first four weeks of this year, around 12 million e-prescriptions were issued in the German ambulatory information systems of CompuGroup Medical (CGM) alone. This means more e-prescriptions than redeemed overall in Germany between July 2021 and early December 2023. Pharmacies using CGM Lauer software have redeemed more than 4 million e-prescriptions in the last four weeks. This is CGM's positive interim balance since e-prescriptions became the new standard in ambulatory healthcare at the beginning of the year.

"500 million prescriptions are issued in Germany every year. Digitizing this process during ongoing practice operations is an enormous challenge. We are mastering it together: Patients have received around 12 million e-prescriptions from CGM customers in the first four weeks of the year. A great achievement by the doctors, practice teams and pharmacists, whom we are happy to provide with comprehensive support. Particularly in view of the complexity of the process, CGM considers the comprehensive introduction of e-prescriptions to be a clear success. With the broad use of e-prescriptions, digitization in the German healthcare system is reaching all patients. This is an important step toward a fully connected healthcare system," says Dr. Ulrich Thomé, Managing Director Ambulatory Information Systems DACH at CGM.

According to CGM, the number of e-prescriptions sent via CLICKDOC has also increased significantly and tripled compared to December. CGM thus offers an alternative to the e-prescription channels via electronic health card, printout or gematik app. CGM's German ambulatory information systems can handle all of these prescription channels. With CLICKDOC, physicians can send secure access to the e-prescription token from the CGM software without any additional effort. Patients receive an encrypted access link via SMS or e-mail. After successfully answering the security question, they can access the e-prescription token with their smartphone. They can redeem their e-prescription at any local pharmacy or online at around 7,500 local pharmacies of their choice, pre-order the medication and, if offered, have it delivered by courier. When ordering over-the-counter products online, patients can see in CLICKDOC if they are in stock. To read the prescription data behind the e-prescription token, the pharmacy needs a connection to the Telematics Infrastructure (TI). The prescription record is always stored in the TI and never leaves it.

Dr. Kirsten Schubert-Fuchs, owner of a gynaecological practice in Oberlungwitz near Chemnitz, says about the electronic prescription via CLICKDOC: "Thanks to CLICKDOC, our patients can see directly on their smartphone that their e-prescription is available. This makes it easier for us as a practice team to explain how e-prescriptions work and is also well received by our patients. They have something in their hands, only fully digital. It also saves a lot of extra work, especially when we have to make subsequent changes to the prescription due to supply bottlenecks or when we issue prescriptions after phone calls or video consultations due to infections."

The digitization of the German healthcare system is gaining momentum. According to gematik, a total of 51 million e-prescriptions have now been redeemed in Germany. This means that the total number has almost tripled since the beginning of the year. According to gematik, the number of medical facilities in Germany that issue e-prescriptions every week is more than 77,000. This compares to 50,000 in the week before Christmas. 17,500, and thus almost all pharmacies in Germany accepted e-prescriptions last week.

 

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.13 billion in 2022, its software products are designed to support all medical and

organizational activities in doctors’ offices, pharmacies, laboratories, hospitals, and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 21 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system



30.01.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language:English
Company:CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone:+49 (0)160 3630362
Fax:+49 (0)261 8000 3200
E-mail:investor@cgm.com
Internet:www.cgm.com
ISIN:DE000A288904
WKN:A28890
Indices:SDAX, TecDAX
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID:1826005

 
End of NewsEQS News Service

1826005  30.01.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1826005&application_name=news&site_id=symex
Voir toutes les actualités de CompuGroup Medical SE & Co. KGaA